Table 1.
CD4+ T Lymphocyte count (CD4) distribution in HIV-1 infected pregnant women diagnosed in five antenatal clinics during voluntary counseling and testing in Abidjan, Côte d’Ivoire, ANRS 1201/1202 Ditrame Plus Project, April-June 2002.
| TOTAL (N=226) | Did not receive ARVs for PMTCT (n=154)
|
Received ARVs for PMTCT (n=72 ) | P * | P ** | ||
|---|---|---|---|---|---|---|
| Did not receive test result (n=54) | Received test result (n=100 ) | |||||
| CD4 measurement (n) | 221 | 50 A | 99 B | 72 C | ||
| Absolute CD4 count | ||||||
| Mean ± SD | 452.5 ± 251.7 | 433.9 ± 326.2 | 466.7 ± 223.0 | 445.8 ± 231.5 | ||
| Median [IQR] | 408 [304 – 570] | 389 [262 – 515] | 425 [313 – 616] | 405 [308 – 516] | ||
| CD4 distribution: | ||||||
| < 200/mm3 | 31 (14.0) | 10 (20.0) | 11 (11.1) | 10 (14.5) | ||
| 200 – 349/mm3 | 47 (21.3) | 12 (24.0) | 22 (22.2) | 13 (18.1) | ||
| 350 – 499/mm3 | 66 (29.9) | 12 (24.0) | 28 (28.3) | 24 (34.8) | ||
| >=500/mm3 | 77 (34.8) | 16 (32.0) | 38 (38.4) | 22 (31.9) | ||
| Percentage of CD4 | ||||||
| Mean ± SD | 26. 2 ± 10.3 | 25.1 ± 10.7 | 26.6 ± 10.5 | 26.4 ± 9.6 | ||
| Median [IQR] | 26.6 [19.5–32.0] | 25.1 [19.3–30.5] | 27.0 [20.0–32.7] | 27.3 [19.6–31.8] | ||
| < 15% | ||||||
IQR: Interquartile range, SD: Standard deviation, DP: Ditrame Plus Project, ARVs: antiretroviral prophylaxis regimen (Zidovudine + Nevirapine), PMTCT: prevention of mother to child transmission of HIV.
*
A vs. B+C
**
A+B vs. C